Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187792 | SCV000241389 | uncertain significance | not provided | 2013-11-26 | criteria provided, single submitter | clinical testing | This variant is denoted p.Ala53Gly (GCC>GGC): c.158 C>G in exon 2 of the KANSL1 gene (NM_001193466.1). The Ala53Gly missense change in the KANSL1 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a conservative substitution of one uncharged, non-polar amino acid for another at a position that is conserved across species. In silico analysis is inconsistent with regard to the effect this variant may have on the protein structure/function. Therefore, based on the currently available information, it is unclear whether Ala53Gly is a disease-causing mutation or a rare benign variant The variant is found in EPILEPSY panel(s). |